Global Therapeutic Nuclear Medicines Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Therapeutic Nuclear Medicines market size will reach 2,915.47 Million USD in 2025 and is projected to reach 8,929.58 Million USD by 2032, with a CAGR of 17.34% (2025-2032). Notably, the China Therapeutic Nuclear Medicines market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Therapeutic nuclear medicine involves the use of radioactive substances, known as radiopharmaceuticals, for the treatment of various medical conditions. Unlike diagnostic nuclear medicine, which focuses on imaging techniques to visualize internal structures and functions, therapeutic nuclear medicine employs radioactive materials to deliver targeted doses of radiation to specific tissues or organs to treat diseases. Common applications of therapeutic nuclear medicine include the treatment of certain types of cancer, such as thyroid cancer, lymphoma, and bone metastases, as well as non-cancerous conditions like hyperthyroidism and certain types of arthritis. Radiopharmaceuticals used in therapeutic nuclear medicine emit radiation that can selectively destroy or inhibit the growth of abnormal cells while minimizing damage to surrounding healthy tissues. This approach allows for precise and localized treatment, often with fewer side effects compared to traditional therapies. Therapeutic nuclear medicine plays a significant role in modern medicine, offering effective treatment options for a wide range of conditions.
The major global manufacturers of Therapeutic Nuclear Medicines include Novartis AG, Bayer, China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus, Acrotech Biopharma., Progenics Pharmaceuticals, International Isotopes, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Therapeutic Nuclear Medicines. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Therapeutic Nuclear Medicines market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Therapeutic Nuclear Medicines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Therapeutic Nuclear Medicines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Therapeutic Nuclear Medicines Include:
Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes
Therapeutic Nuclear Medicines Product Segment Include:
Radium-223
Lutetium-177
Iodine-131
Other
Therapeutic Nuclear Medicines Product Application Include:
Thyroid
Bone Metastasis
Lymphoma
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Therapeutic Nuclear Medicines Industry PESTEL Analysis
Chapter 3: Global Therapeutic Nuclear Medicines Industry Porter's Five Forces Analysis
Chapter 4: Global Therapeutic Nuclear Medicines Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Therapeutic Nuclear Medicines Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Therapeutic Nuclear Medicines Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Therapeutic Nuclear Medicines Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Therapeutic Nuclear Medicines market size will reach 2,915.47 Million USD in 2025 and is projected to reach 8,929.58 Million USD by 2032, with a CAGR of 17.34% (2025-2032). Notably, the China Therapeutic Nuclear Medicines market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Therapeutic nuclear medicine involves the use of radioactive substances, known as radiopharmaceuticals, for the treatment of various medical conditions. Unlike diagnostic nuclear medicine, which focuses on imaging techniques to visualize internal structures and functions, therapeutic nuclear medicine employs radioactive materials to deliver targeted doses of radiation to specific tissues or organs to treat diseases. Common applications of therapeutic nuclear medicine include the treatment of certain types of cancer, such as thyroid cancer, lymphoma, and bone metastases, as well as non-cancerous conditions like hyperthyroidism and certain types of arthritis. Radiopharmaceuticals used in therapeutic nuclear medicine emit radiation that can selectively destroy or inhibit the growth of abnormal cells while minimizing damage to surrounding healthy tissues. This approach allows for precise and localized treatment, often with fewer side effects compared to traditional therapies. Therapeutic nuclear medicine plays a significant role in modern medicine, offering effective treatment options for a wide range of conditions.
The major global manufacturers of Therapeutic Nuclear Medicines include Novartis AG, Bayer, China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus, Acrotech Biopharma., Progenics Pharmaceuticals, International Isotopes, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Therapeutic Nuclear Medicines. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Therapeutic Nuclear Medicines market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Therapeutic Nuclear Medicines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Therapeutic Nuclear Medicines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Therapeutic Nuclear Medicines Include:
Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes
Therapeutic Nuclear Medicines Product Segment Include:
Radium-223
Lutetium-177
Iodine-131
Other
Therapeutic Nuclear Medicines Product Application Include:
Thyroid
Bone Metastasis
Lymphoma
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Therapeutic Nuclear Medicines Industry PESTEL Analysis
Chapter 3: Global Therapeutic Nuclear Medicines Industry Porter's Five Forces Analysis
Chapter 4: Global Therapeutic Nuclear Medicines Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Therapeutic Nuclear Medicines Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Therapeutic Nuclear Medicines Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Therapeutic Nuclear Medicines Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Therapeutic Nuclear Medicines Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Therapeutic Nuclear Medicines Product by Type
- 1.2.1 Radium-223
- 1.2.2 Lutetium-177
- 1.2.3 Iodine-131
- 1.2.4 Other
- 1.3 Therapeutic Nuclear Medicines Product by Application
- 1.3.1 Thyroid
- 1.3.2 Bone Metastasis
- 1.3.3 Lymphoma
- 1.3.4 Other
- 1.4 Global Therapeutic Nuclear Medicines Market Revenue and Sales Analysis
- 1.4.1 Global Therapeutic Nuclear Medicines Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Therapeutic Nuclear Medicines Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Therapeutic Nuclear Medicines Market Sales Price Trend Analysis (2020-2032)
- 1.5 Therapeutic Nuclear Medicines Market Development Status and Trends
- 1.5.1 Therapeutic Nuclear Medicines Industry Development Status Analysis
- 1.5.2 Therapeutic Nuclear Medicines Industry Development Trends Analysis
- 2 Therapeutic Nuclear Medicines Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Therapeutic Nuclear Medicines Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Therapeutic Nuclear Medicines Market Analysis by Country
- 4.1 Global Therapeutic Nuclear Medicines Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Therapeutic Nuclear Medicines Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Therapeutic Nuclear Medicines Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Therapeutic Nuclear Medicines Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Therapeutic Nuclear Medicines Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Therapeutic Nuclear Medicines Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Therapeutic Nuclear Medicines Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Therapeutic Nuclear Medicines Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Therapeutic Nuclear Medicines Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Therapeutic Nuclear Medicines Average Sales Price by Manufacturers (2021-2025)
- 5.2 Therapeutic Nuclear Medicines Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Therapeutic Nuclear Medicines Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Therapeutic Nuclear Medicines Market Analysis by Type
- 6.1 Global Therapeutic Nuclear Medicines Market Revenue Analysis by Type
- 6.1.1 Global Therapeutic Nuclear Medicines Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Therapeutic Nuclear Medicines Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Therapeutic Nuclear Medicines Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Therapeutic Nuclear Medicines Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Novartis AG
- 7.1.1 Novartis AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Novartis AG Therapeutic Nuclear Medicines Product Portfolio
- 7.1.3 Novartis AG Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Bayer
- 7.2.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Bayer Therapeutic Nuclear Medicines Product Portfolio
- 7.2.3 Bayer Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 China Isotope & Radiation
- 7.3.1 China Isotope & Radiation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolio
- 7.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Q BioMed
- 7.4.1 Q BioMed Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Q BioMed Therapeutic Nuclear Medicines Product Portfolio
- 7.4.3 Q BioMed Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Curium Pharmaceuticals
- 7.5.1 Curium Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
- 7.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Jubilant DraxImage
- 7.6.1 Jubilant DraxImage Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolio
- 7.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Dongcheng
- 7.7.1 Dongcheng Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Dongcheng Therapeutic Nuclear Medicines Product Portfolio
- 7.7.3 Dongcheng Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Lantheus
- 7.8.1 Lantheus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Lantheus Therapeutic Nuclear Medicines Product Portfolio
- 7.8.3 Lantheus Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Acrotech Biopharma.
- 7.9.1 Acrotech Biopharma. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Portfolio
- 7.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Progenics Pharmaceuticals
- 7.10.1 Progenics Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
- 7.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 International Isotopes
- 7.11.1 International Isotopes Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 International Isotopes Therapeutic Nuclear Medicines Product Portfolio
- 7.11.3 International Isotopes Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Therapeutic Nuclear Medicines Industry Chain Analysis
- 8.2 Therapeutic Nuclear Medicines Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Therapeutic Nuclear Medicines Product Downstream Application Analysis
- 8.3.1 Global Therapeutic Nuclear Medicines Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Therapeutic Nuclear Medicines Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Therapeutic Nuclear Medicines Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Therapeutic Nuclear Medicines Typical Downstream Customers
- 8.5 Therapeutic Nuclear Medicines Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
